{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:18:13Z","timestamp":1788653893630,"version":"build-2803163510"},"reference-count":51,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Breast cancer among Emirati patients is characterized by early-onset disease and later stages at presentation. Little is known about the germline genetic variants that may contribute to these observations. The goal of this study is to characterize the rate and implications of germline genetic variants among a cohort of Emirati patients at risk for hereditary breast and ovarian cancer syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>A retrospective study was performed to analyze the results of clinical germline genetic testing (March 2020-January 2023) among a cohort of consecutive Emirati patients at risk for hereditary breast and ovarian cancer syndrome: group A: patients with personal history of breast or ovarian cancer (n = 135); group B: unaffected patients with family history of breast or ovarian cancer (n = 37); and group C: patients presenting for cascade testing (n = 20). Management of patients identified to have pathogenic\/likely pathogenic (P\/LP) variants was analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              The rate of P\/LP germline variants for each group was: group A: 17.3%, group B: 16.6%, group C: 57.9%.\n              <jats:italic>BRCA1<\/jats:italic>\n              gene was the most commonly identified gene harboring P\/LP variants, followed by\n              <jats:italic>BRCA2<\/jats:italic>\n              , among this cohort. Four unrelated patients had a recurrent\n              <jats:italic>BRCA1<\/jats:italic>\n              pathogenic variant: c.4065_4068del (p.Asn1355Lysfs*10). Only two patients in this series elected risk-reducing mastectomy and four patients elected risk-reducing bilateral salpingo-oophorectomy.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>A higher rate of P\/LP variants is seen among Emirati patients at risk for hereditary breast and ovarian cancer syndrome compared with reports of similar patients from Western populations. Efforts to increase utilization and awareness of germline genetic testing are warranted among Emirati patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go-24-00352","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T21:00:22Z","timestamp":1731618022000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":5,"title":["Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome"],"prefix":"10.1200","author":[{"given":"Rifaat R.","family":"Rawashdeh","sequence":"first","affiliation":[{"name":"Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4325-8370","authenticated-orcid":true,"given":"Holly","family":"Pederson","sequence":"additional","affiliation":[{"name":"Genomic Medicine Institute and Center for Personalized Genetic Healthcare, Cleveland Clinic Main Campus, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-3252","authenticated-orcid":true,"given":"Rafal","family":"Iskanderian","sequence":"additional","affiliation":[{"name":"Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad","family":"Khan","sequence":"additional","affiliation":[{"name":"Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Altrabulsi","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ricci","sequence":"additional","affiliation":[{"name":"Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Eng","sequence":"additional","affiliation":[{"name":"Genomic Medicine Institute and Center for Personalized Genetic Healthcare, Cleveland Clinic Main Campus, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Jallad","sequence":"additional","affiliation":[{"name":"Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma Ibrahim","family":"Al Mannaei","sequence":"additional","affiliation":[{"name":"Department of Health, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0673-7997","authenticated-orcid":true,"given":"Mohamed Salem","family":"Alameri","sequence":"additional","affiliation":[{"name":"Department of Health, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Attia","sequence":"additional","affiliation":[{"name":"Clinical Genomics, M42, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9796-4267","authenticated-orcid":true,"given":"Stephen R.","family":"Grobmyer","sequence":"additional","affiliation":[{"name":"Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","unstructured":"Breast cancer statistics. World Cancer Research Fund International. wcrf.org"},{"key":"e_1_3_5_3_2","unstructured":"Cancer incidence in United Arab Emirates annual report of the UAE\u2014National Cancer Registry 2019. www.mohap.gov.ae"},{"key":"e_1_3_5_4_2","first-page":"25","article-title":"Clinical and pathological characteristics of breast cancer among Emirati national patients","volume":"44","author":"Iskanderian RR","year":"2024","unstructured":"Iskanderian RR, Matalkah A, Jallad B, et al: Clinical and pathological characteristics of breast cancer among Emirati national patients. Gulf J Onc 44:25-29, 2024","journal-title":"Gulf J Onc"},{"key":"e_1_3_5_5_2","article-title":"Breast cancer in the United Arab Emirates","author":"Al-Shamsi HO","unstructured":"Al-Shamsi HO, Abdelwahed N, Al-Awadhi A, et al: Breast cancer in the United Arab Emirates. JCO Glob Oncol 10.1200\/GO.22.00247","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0202-0"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913948"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005936"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2020.07.005"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.e13509"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.09.159"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105215"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07549-8"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.10987"},{"key":"e_1_3_5_16_2","article-title":"Cascade genetic testing for hereditary cancer risk: An underutilized tool for cancer prevention","author":"Whitaker KD","unstructured":"Whitaker KD, Obeid E, Daly MB, et al: Cascade genetic testing for hereditary cancer risk: An underutilized tool for cancer prevention. JCO Precis Oncol 10.1200\/PO.21.00163","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_5_17_2","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) genetic\/familial high-risk assessment version high-risk assessment: Breast ovarian and pancreatic version 2.2024 2023. https:\/\/www.nccn.org"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01631"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.15406\/jcpcr.2018.09.00334"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.534"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757956"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.32787"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02225"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30498"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23736"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31601"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040956"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4635-4"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2009.04.010"},{"key":"e_1_3_5_30_2","first-page":"1993","volume-title":"GeneReviews\u00ae","author":"Varon R","year":"1999","unstructured":"Varon R, Demuth I, Chrzanowska KH: Nijmegen breakage syndrome, in Adam MP, Feldman J, Mirzaa GM, et al (eds): GeneReviews\u00ae. Seattle, WA, University of Washington, Seattle, 1999, pp 1993-2023"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes12101520"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400210"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1947"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a005652"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20121303"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.10.024"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.01.022"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0021932097004914"},{"key":"e_1_3_5_39_2","first-page":"15708","article-title":"CHEK2 mutation and risk of prostate cancer: A systematic review and meta-analysis","volume":"8","author":"Wang Y","year":"2015","unstructured":"Wang Y, Dai B, Ye D: CHEK2 mutation and risk of prostate cancer: A systematic review and meta-analysis. Int J Clin Exp Med 8:15708-15715, 2015","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/426403"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29426"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2021.09.005"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201734"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2020.09.006"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijc.IJC_73_18"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-017-0456-1"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.1414"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.08.015"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0446-1"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02347-3"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-012-9539-1"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e318163487d"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-24-00352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T21:00:26Z","timestamp":1731618026000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-24-00352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1200\/GO-24-00352"],"URL":"https:\/\/doi.org\/10.1200\/go-24-00352","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-07-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400352"}}